Related Experiment Video
Updated: Dec 26, 2025
09:34
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
Published on: February 9, 2019
9.3K
Lipid Drug Conjugates for Improved Therapeutic Benefits
Priya Shrivastava1, Laxmikant Gautam1, Anamika Jain1
1Drug Delivery and Research Laboratory, Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar, (M.P.), 470003, India.
Current Pharmaceutical Design
|March 13, 2020
Summary
Lipid drug conjugates (LDCs) enhance drug delivery by improving hydrophobicity and payload. These lipoidal prodrugs offer improved tumor targeting, bioavailability, and reduced toxicity, often utilizing nanocarrier systems for stability.
Area of Science:
- Pharmaceutical Chemistry
- Drug Delivery Systems
- Bioconjugation Chemistry
Background:
- Lipid drug conjugates (LDCs) are lipoidal prodrugs linking bioactive molecules to lipids.
- They are designed to increase drug payload and prevent leakage of polar compounds.
- Conjugation improves hydrophobicity and modifies bioactive molecule characteristics.
Purpose of the Study:
- To review the potential of LDCs for enhancing therapeutic indices.
- To summarize conjugation methods, lipids used, and advantages of LDCs.
- To explore the use of LDCs in nanocarrier systems.
Main Methods:
- Review of existing literature on LDC synthesis and applications.
- Analysis of various conjugation approaches, chemical linkers, and spacers.
- Examination of LDC incorporation into nanocarrier systems like nanoparticles and liposomes.
Main Results:
- LDCs demonstrate enhanced tumor and lymphatic system targeting.
- Improved systemic bioavailability and decreased toxicity are key benefits.
- Lipidic components improve drug loading and stability within nanocarriers.
Conclusions:
- LDCs represent a promising strategy for improving drug efficacy and safety.
- The choice of conjugation method and lipid is critical for controlled release.
- Integration with nanocarriers further optimizes LDC performance and stability.
Related Concept Videos
01:27Bioavailability Enhancement: Drug Permeability Enhancement
142
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
142
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.2K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.2K
01:16Drug Biotransformation: Overview
3.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.4K
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
146
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
146
01:14Phase II Conjugation Reactions: Overview
666
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
666
01:30Prodrugs
3.7K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
3.7K